Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X:
“ESMOTAT 26 is wrapping up!
It was a great pleasure to discuss ADCs from an industry perspective with Barbara Pistill
and Funda Meric-Bernstam!
Bonus: updated ADC landscape with same format of our Cancer Discovery 2024 review and some fun with ADC PK”
Other articles featuring Raffaele Colombo on OncoDaily.
